Contribute Try STAT+ Today

Good morning, everyone, and how are you today? We are doing just fine, thank you, as we look around and notice blue skies, chirping birds, a fast-growing official mascot barking at wildlife and a short person hunched over a laptop. Sometimes, the cup of stimulation is half full, as they say. Speaking of which, time to fire up the coffee kettle. Our choice today, for those who track this sort of thing, is coconut. And of course, it is also time to get cracking. Here are some tidbits to help you along. Have a productive day and do stay safe. …

President Trump plans to name Moncef Slaoui, a former GlaxoSmithKline (GSK) vaccines head, and Gustave Perna, a four-star U.S. general, to lead a Manhattan Project-style effort to develop a Covid-19 vaccineBloomberg News reports. The program will pull together drug makers, government agencies, and the military, with the goal of cutting development time for a vaccine by up to eight months and producing 300 million doses by the end of the year. Slaoui is on the board of Moderna (MRNA), one of the leading U.S. companies developing a vaccine, but will leave that as well as other boards.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.